J. A. M. Raaijmakers

1.7k total citations
44 papers, 1.3k citations indexed

About

J. A. M. Raaijmakers is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, J. A. M. Raaijmakers has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in J. A. M. Raaijmakers's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (7 papers) and Mycobacterium research and diagnosis (6 papers). J. A. M. Raaijmakers is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (7 papers) and Mycobacterium research and diagnosis (6 papers). J. A. M. Raaijmakers collaborates with scholars based in Netherlands, United States and Sweden. J. A. M. Raaijmakers's co-authors include Leo Koenderman, Anja van de Stolpe, Paul T. van der Saag, Eric Caldenhoven, Johan Lidén, Sam Okret, Jan‐Åke Gustafsson, Sacha Wissink, J. P. Johnson and Barbara Stade and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Allergy and Clinical Immunology.

In The Last Decade

J. A. M. Raaijmakers

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. A. M. Raaijmakers Netherlands 17 417 409 318 278 214 44 1.3k
Abbie Celniker United States 19 538 1.3× 257 0.6× 564 1.8× 85 0.3× 148 0.7× 29 1.8k
James B. Breitmeyer United States 23 653 1.6× 192 0.5× 609 1.9× 86 0.3× 171 0.8× 60 2.1k
Christopher J. Larson United States 23 242 0.6× 231 0.6× 675 2.1× 188 0.7× 182 0.9× 47 1.8k
Balakrishna L. Lokeshwar United States 19 158 0.4× 99 0.2× 422 1.3× 237 0.9× 141 0.7× 32 1.8k
Antonella Daniele Italy 23 201 0.5× 214 0.5× 436 1.4× 340 1.2× 157 0.7× 64 1.6k
Konrad Pazdrak United States 22 575 1.4× 493 1.2× 324 1.0× 106 0.4× 39 0.2× 44 1.4k
Jee Hyun Lee South Korea 16 474 1.1× 115 0.3× 445 1.4× 268 1.0× 101 0.5× 67 1.6k
Xinhua Yu Germany 24 412 1.0× 323 0.8× 578 1.8× 89 0.3× 215 1.0× 84 1.7k
Keigyou Yoh Japan 27 1.1k 2.7× 280 0.7× 1.2k 3.7× 124 0.4× 167 0.8× 65 2.8k
M Yamakido Japan 18 297 0.7× 1.2k 2.9× 809 2.5× 115 0.4× 202 0.9× 117 2.3k

Countries citing papers authored by J. A. M. Raaijmakers

Since Specialization
Citations

This map shows the geographic impact of J. A. M. Raaijmakers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. A. M. Raaijmakers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. A. M. Raaijmakers more than expected).

Fields of papers citing papers by J. A. M. Raaijmakers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. A. M. Raaijmakers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. A. M. Raaijmakers. The network helps show where J. A. M. Raaijmakers may publish in the future.

Co-authorship network of co-authors of J. A. M. Raaijmakers

This figure shows the co-authorship network connecting the top 25 collaborators of J. A. M. Raaijmakers. A scholar is included among the top collaborators of J. A. M. Raaijmakers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. A. M. Raaijmakers. J. A. M. Raaijmakers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raaijmakers, J. A. M., Rob E. Aarnoutse, Elin M. Svensson, et al.. (2025). Bedaquiline does not enhance a clofazimine-azithromycin-ethambutol regimen against Mycobacterium avium in the hollow-fiber system. Antimicrobial Agents and Chemotherapy. 69(5). e0146424–e0146424.
2.
Raaijmakers, J. A. M., Rob E. Aarnoutse, Elin M. Svensson, et al.. (2024). Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model. Antimicrobial Agents and Chemotherapy. 68(3). e0115723–e0115723. 5 indexed citations
3.
Raaijmakers, J. A. M., Mike Marvin Ruth, Jodie A. Schildkraut, et al.. (2024). Replacing rifampicin with minocycline increases the activity of the treatment regimen for Mycobacterium avium complex pulmonary disease in a dynamic hollow-fibre system. International Journal of Antimicrobial Agents. 65(2). 107423–107423. 1 indexed citations
4.
Gooyert, Vincent de, et al.. (2024). District heating with complexity: Anticipating unintended consequences in the transition towards a climate-neutral city in the Netherlands. Energy Research & Social Science. 110. 103450–103450. 10 indexed citations
5.
Schildkraut, Jodie A., J. A. M. Raaijmakers, Rob E. Aarnoutse, et al.. (2023). The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease. Antimicrobial Agents and Chemotherapy. 67(11). e0087423–e0087423. 12 indexed citations
6.
Raaijmakers, J. A. M., Rob ter Heine, Ruben L. Smeets, et al.. (2023). Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum. Journal of Antimicrobial Chemotherapy. 78(11). 2723–2730. 5 indexed citations
7.
Ingen, Jakko van, Saskia Kuipers, Cécile Magis-Escurra, et al.. (2022). New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians. Respiration. 102(2). 83–100. 23 indexed citations
8.
Heine, Rob ter, Jeroen Schouten, J. A. M. Raaijmakers, et al.. (2022). An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients. Clinical Pharmacokinetics. 61(6). 907–918. 11 indexed citations
9.
Ruth, Mike Marvin, J. A. M. Raaijmakers, Rob E. Aarnoutse, et al.. (2021). Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fibre system that simulates human plasma and epithelial lining fluid pharmacokinetics. Clinical Microbiology and Infection. 28(3). 448.e1–448.e7. 10 indexed citations
10.
Farzan, Niloufar, et al.. (2016). Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review. Clinical & Experimental Allergy. 47(2). 271–293. 30 indexed citations
11.
Frederix, G. W. J., Johan L. Severens, Anke M. Hövels, et al.. (2014). Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium. European Journal of Cancer Care. 24(3). 340–354. 4 indexed citations
12.
Frederix, G. W. J., Johan L. Severens, Anke M. Hövels, et al.. (2013). Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer. Breast Cancer Research and Treatment. 139(2). 489–495.
13.
Koster, Ellen S., Anke H. Maitland‐van der Zee, Roger Tavendale, et al.. (2011). FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children. Allergy. 66(12). 1546–1552. 50 indexed citations
14.
Koster, Ellen S., Cornelis K. van der Ent, Cuno S.P.M. Uiterwaal, et al.. (2011). Asthma medication use in infancy: determinants related to prescription of drug therapy. Family Practice. 28(4). 377–384. 5 indexed citations
15.
Vijverberg, Susanne J. H., Leo Koenderman, Ellen S. Koster, et al.. (2011). Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clinical & Experimental Allergy. 41(5). 615–629. 38 indexed citations
16.
Breekveldt‐Postma, Nancy S., Charles M. Gerrits, J.-W.J. Lammers, J. A. M. Raaijmakers, & Ron M. C. Herings. (2004). Persistence with inhaled corticosteroid therapy in daily practice. Respiratory Medicine. 98(8). 752–759. 44 indexed citations
17.
Koenderman, Leo, et al.. (1995). C5a-Induced Migration of Human Monocytes is Primed by Dexamethasone. American Journal of Respiratory Cell and Molecular Biology. 12(6). 691–696. 12 indexed citations
18.
Maikoe, Tjander, et al.. (1995). Cognate interaction between human lymphocytes and eosinophils is mediated by beta 2-integrins and very late antigen-4.. PubMed. 126(3). 261–8. 11 indexed citations
19.
Overveld, Frans J. van, et al.. (1988). The Isolation of Human Lung Mast Cells by Affinity Chromatography. Scandinavian Journal of Immunology. 27(1). 1–6. 4 indexed citations
20.
Raaijmakers, J. A. M., et al.. (1984). Muscarinic Cholinergic Receptors in Peripheral Lung Tissue of Normal Subjects and of Patients with Chronic Obstructive Lung Disease. Clinical Science. 66(5). 585–590. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026